Menu

A new CMS proposed rule would codify the MDPNP and end a practice that allows drugmakers that modify their products to avoid being subject to negotiation.

CMS Looks to Crack Down on Medicare Drug Price Negotiation Loophole

June 16, 2026 Shannon Young, Managing Editor 340B Report Views

Federal health officials last week released a proposal that would codify the federal Medicare Drug Price Negotiation Program (MDPNP) beginning [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Three Drugmakers Exempt New States from Contract Pharmacy, Claims Data Policies

Drug Channels’ Adam Fein: 340B Entering New ‘Era of Transparency’